drugset / Trial / NCT01732237

A Study to Investigate the Pharmacokinetics of JNJ-42396302, JNJ-53773187 and JNJ-42692507 in Healthy Male Participants

NCT01732237 ↗

Phase 1 Completed 18 enrolled Janssen-Cilag International NV
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to investigate the pharmacokinetics (what the body does to the medication) of JNJ-42396302, JNJ-53773187 and JNJ-42692507 after administration of a single oral dose of 100 micrograms under fasted conditions in healthy male participants.

Timeline

Start
2012-08
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-42396302 Small molecule 100 ug Oral
Subject JNJ-42692507 Unknown 100 ug Oral
Subject JNJ-53773187 Unknown 100 ug Oral

Indications

No indication recorded.